Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jyotsana Singhal

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Experimental and Therapeutic Medicine|June 8, 2026
Fatty acid-activated proton transporter SR4 prevents hepatic steatosis and metabolic alterations in diabetic mice by improving mitochondria function, energy balance and oxidative stressJames Figarola, Jyotsana Singhal, Sharad Singhal
Biochemical Pharmacology|May 12, 2009
hSET1: a novel approach for colon cancer therapySushma Yadav, Jyotsana Singhal, Sharad S Singhal, et al.
Biochemical Pharmacology|November 6, 2008
RLIP76: A novel glutathione-conjugate and multi-drug transporterSharad S Singhal, Sushma Yadav, Cherice Roth, et al.
Oncotarget|January 18, 2019
Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomasJames L Figarola, Jyotsana Singhal, Sharad Singhal, et al.
The Journal of Biological Chemistry|May 14, 2008
Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1Sharad S Singhal, Sushma Yadav, Kenneth Drake, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 18, 2021
Activating p53 function by targeting RLIPSharad S Singhal, David Horne, Jyotsana Singhal, et al.
Plos One|September 21, 2011
RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndromeJyotsana Singhal, Lokesh Nagaprashantha, Rit Vatsyayan, et al.
Pharmaceutical Research|May 30, 2015
RLIP76 Targeted Therapy for Kidney CancerSharad S Singhal, Jyotsana Singhal, James Figarola, et al.
Molecular Carcinogenesis|October 19, 2011
Nutlin-3 enhances sorafenib efficacy in renal cell carcinomaRit Vatsyayan, Jyotsana Singhal, Lokesh Dalasanur Nagaprashantha, et al.
Plos One|April 18, 2012
RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancerKathryn Leake, Jyotsana Singhal, Lokesh Dalasanur Nagaprashantha, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Experimental and Therapeutic Medicine|June 8, 2026
Fatty acid-activated proton transporter SR4 prevents hepatic steatosis and metabolic alterations in diabetic mice by improving mitochondria function, energy balance and oxidative stressJames Figarola, Jyotsana Singhal, Sharad Singhal
Biochemical Pharmacology|May 12, 2009
hSET1: a novel approach for colon cancer therapySushma Yadav, Jyotsana Singhal, Sharad S Singhal, et al.
Biochemical Pharmacology|November 6, 2008
RLIP76: A novel glutathione-conjugate and multi-drug transporterSharad S Singhal, Sushma Yadav, Cherice Roth, et al.
Oncotarget|January 18, 2019
Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomasJames L Figarola, Jyotsana Singhal, Sharad Singhal, et al.
The Journal of Biological Chemistry|May 14, 2008
Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1Sharad S Singhal, Sushma Yadav, Kenneth Drake, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 18, 2021
Activating p53 function by targeting RLIPSharad S Singhal, David Horne, Jyotsana Singhal, et al.
Plos One|September 21, 2011
RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndromeJyotsana Singhal, Lokesh Nagaprashantha, Rit Vatsyayan, et al.
Pharmaceutical Research|May 30, 2015
RLIP76 Targeted Therapy for Kidney CancerSharad S Singhal, Jyotsana Singhal, James Figarola, et al.
Molecular Carcinogenesis|October 19, 2011
Nutlin-3 enhances sorafenib efficacy in renal cell carcinomaRit Vatsyayan, Jyotsana Singhal, Lokesh Dalasanur Nagaprashantha, et al.
Plos One|April 18, 2012
RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancerKathryn Leake, Jyotsana Singhal, Lokesh Dalasanur Nagaprashantha, et al.
Pageof 7